Skip to Main Content

Author Details

Michael M Lieber
Mayo Clinic College of Medicine
1973
340
82
PMIDPaper TitleJournal TitlePublished Year
31336126The induction and maintenance of in vitro plant morphogenesis as viewed from a new perspective, with theoretical and constructive implications.Biosystems2019
24139354Racial differences in longitudinal changes in serum prostate-specific antigen levels: the Olmsted County Study and the Flint Men's Health Study.Urology2014
25028457Factors associated with adherence to an end-of-study biopsy: lessons from the prostate cancer prevention trial (SWOG-Coordinated Intergroup Study S9217).Cancer Epidemiol Biomarkers Prev2014
24640421New practical and theoretical approaches to the induction of morphogenesis from plant tumors in vitro using new types of plant growth regulators: towards constructive paradigms in agriculture and medicine.Theor Biol Forum2013
22112286Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.Urology2012
22471348Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting.BJU Int2012
22212966Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.Mayo Clin Proc2012
22233166Nocturia is associated with an increased risk of coronary heart disease and death.BJU Int2012
22386420Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.Urology2012
22093190Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.J Urol2012
22093189Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men.J Urol2012
20800880Estimation of prostate size in community-dwelling men.Urology2011
22220357The problem of antibiotic resistant bacteria. The important role of environmentally responsive mutagenesis, its relevance to a new paradigm that may allow a solution.Theor Biol Forum2011
21990298Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).JAMA2011
21520274Fracture risk in men with prostate cancer: a population-based study.J Bone Miner Res2011
21676443Associations between modest weight changes and onset and progression of lower urinary tract symptoms in two population-based cohorts.Urology2011
21367876Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.Am J Epidemiol2011
21481131Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.BJU Int2011
20845055Measures of autonomic nervous system activity and lower urinary tract symptoms.Clin Auton Res2011
20804476Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms.BJU Int2011
19594737Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times.BJU Int2010
20620405The association between statin use and the diagnosis of prostate cancer in a population based cohort.J Urol2010
19220246Presumed circle area ratio of the prostate in a community-based group of men.BJU Int2009
19647300Three-dimensional ultrasound bladder characteristics and their association with prostate size and lower urinary tract dysfunction among men in the community.Urology2009
19837429Intravesical prostatic protrusion in men in Olmsted County, Minnesota.J Urol2009
19428080Alpha-blocker use is associated with decreased risk of sexual dysfunction.Urology2009
19395697Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.Am J Epidemiol2009
19570040Longitudinal evaluation of sexual function in a male cohort: the Olmsted county study of urinary symptoms and health status among men.J Sex Med2009
19181643A population-based, longitudinal study of erectile dysfunction and future coronary artery disease.Mayo Clin Proc2009
19152343Smoking and acute urinary retention: the Olmsted County study of urinary symptoms and health status among men.Prostate2009
19066370Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).JAMA2009
18086163Snoring as a risk factor for sexual dysfunction in community men.J Sex Med2008
19064575Psychosocial factors associated with an increased frequency of prostate cancer screening in men ages 40 to 79 years: the Olmsted County study.Cancer Epidemiol Biomarkers Prev2008
18624959The associations between serum sex hormones, erectile function, and sex drive: the Olmsted County Study of Urinary Symptoms and Health Status among Men.J Sex Med2008
18342190Longitudinal association between prostatitis and development of benign prostatic hyperplasia.Urology2008
18071006Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.Diabetes Care2008
17382749Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men.J Urol2007
18068451Population-based case-control study of PSA and DRE screening on prostate cancer mortality.Urology2007
16302261Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia.Prostate2006
17095073Radical prostatectomy for octogenarians: how old is too old?Urology2006
17169156Dropout in a longitudinal, cohort study of urologic disease in community men.BMC Med Res Methodol2006
17183765Bacteriophage research: its deeper significance for science.Riv Biol2006
16791794Towards an understanding of the role of forces in carcinogenesis: a perspective with therapeutic implications.Riv Biol2006
16905643Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia.Am J Epidemiol2006
16489065PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer.Clin Cancer Res2006
16413325Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota.Urology2006
16516013Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo.J Urol2006
16469608Tracking of longitudinal changes in measures of benign prostatic hyperplasia in a population based cohort.J Urol2006
16466847Correlations between longitudinal changes in transitional zone volume and measures of benign prostatic hyperplasia in a population-based cohort.Eur Urol2006
16461080Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men.Urology2006
  • 1 - 50 of 340

Recommended Authors

Career Start Year 1995
Number of shared co-authors 0
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 4
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 6
The Institute of Cancer Research
Career Start Year 1993
Number of shared co-authors 3
University Health Network, Princess Margaret Cancer Center, University of Toronto
Career Start Year 1993
Number of shared co-authors 4
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 3
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 0
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1989
Number of shared co-authors 3
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 3
University of Oxford
Career Start Year 1987
Number of shared co-authors 10
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 5
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 12
Yale University School of Medicine
Career Start Year 1986
Number of shared co-authors 5
University of British Columbia
Career Start Year 1985
Number of shared co-authors 2
Johns Hopkins University School of Medicine
Career Start Year 1984
Number of shared co-authors 5
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 7
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 3
University of Oxford, John Radcliffe Hospital
Career Start Year 1981
Number of shared co-authors 10
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 5
University of Toronto
Career Start Year 1980
Number of shared co-authors 5
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 2
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 2
National Cancer Institute, National Institutes of Health
Career Start Year 1977
Number of shared co-authors 1
The Institute of Cancer Research
Career Start Year 1977
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 1975
Number of shared co-authors 1
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1975
Number of shared co-authors 3
CHU de Quebec-Universite Laval
Career Start Year 1975
Number of shared co-authors 6
University Health Network, University of Toronto
Career Start Year 1974
Number of shared co-authors 9
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 1
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 3

Collaborators

Kaiser Permanente Southern California
Co-authored papers 117
University of North Carolina at Chapel Hill
Co-authored papers 83
Mayo Clinic
Co-authored papers 50
University of North Carolina at Chapel Hill
Co-authored papers 39
Merck & Co., Inc.
Co-authored papers 36
Mayo Clinic
Co-authored papers 33
Mayo Clinic
Co-authored papers 27
Brown University, Brown University Warren Alpert Medical School, Dartmouth-Hitchcock Medical Center, Harvard School of Public Health, Johns Hopkins Medicine, Mayo Clinic Minnesota
Co-authored papers 23
Section of Health Services Evaluation, Mayo Clinic
Co-authored papers 21
St. Jude Children's Research Hospital
Co-authored papers 13
Mayo Clinic
Co-authored papers 11
Mayo Clinic
Co-authored papers 9
Inova Health System
Co-authored papers 6
Mayo Clinic
Co-authored papers 5
CHRISTUS Santa Rosa Hospital-Medical Center
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
Co-authored papers 5
Mayo Clinic
Co-authored papers 5
University of Edinburgh
Co-authored papers 4
Moores Cancer Center, university of california san diego
Co-authored papers 4
University of Colorado School of Medicine
Co-authored papers 4
Marshfield Clinic Research Institute
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Epstein Health LLC
Co-authored papers 3
Mayo Clinic
Co-authored papers 3
VA Boston Healthcare System
Co-authored papers 3
PHusis Therapeutics Inc.
Co-authored papers 3
University of Newcastle
Co-authored papers 3
College of Public Health, University of South Florida
Co-authored papers 3